Ambisome and Blind - a phase IV clinical study of FDA data

Summary:

Blind is reported as a side effect among people who take Ambisome (amphotericin b), especially for people who are male, 2-9 old, have been taking the drug for < 1 month also take Vancomycin, and have Acute myeloid leukaemia.

The phase IV clinical study analyzes which people have Blind when taking Ambisome. It is created by eHealthMe based on reports of 7,928 people who have side effects when taking Ambisome from the FDA, and is updated regularly.

What is Ambisome?

Ambisome has active ingredients of amphotericin b. eHealthMe is studying from 7,934 Ambisome users. Check the latest studies of Ambisome.

What is Blind?

Blind is found to be associated with 2,281 drugs and 1,972 conditions by eHealthMe. Check the latest studies of Blind.

On Jul, 21, 2026

7,928 people reported to have side effects when taking Ambisome.
Among them, 14 people (0.18%) have Blind.

Among these 14 people:

How long have people been on Ambisome when they have Blind? *

What is the gender of people who have Blind when taking Ambisome? *

female: 50 %
male: 50 %

What is the age of people who have Blind when taking Ambisome? *

What are other drugs people take besides Ambisome? *

What are other side effects people have besides Blind? *

Drug Ineffective: 3 people, 21.43%
Blindness Unilateral: 3 people, 21.43%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 3 people, 21.43%
Cranial Nerve Disorder (impaired functioning of one of the twelve cranial nerves): 3 people, 21.43%
Nephropathy Toxic (damage to kidney due to toxins): 3 people, 21.43%
Cerebral Aspergillosis (pus collection with swelling in brain): 3 people, 21.43%
Osteolysis (dissolution of bone): 3 people, 21.43%
Multi-Organ Failure (multisystem organ failure): 2 people, 14.29%
Electroencephalogram Abnormal: 2 people, 14.29%
Thrombocytopenia (decrease of platelets in blood): 2 people, 14.29%

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 4 people, 28.57%
Tumor: 3 people, 21.43%
Thrombocytopenia (decrease of platelets in blood): 1 person, 7.14%
Rashes (redness): 1 person, 7.14%
Pain: 1 person, 7.14%
Mycotic Corneal Ulcer (ulcer of cornea due to fungal infection): 1 person, 7.14%
Multiple Myeloma (cancer of the plasma cells): 1 person, 7.14%
Mucormycosis (a rare infection caused by organisms that belong to a group of fungi called mucoromycotina): 1 person, 7.14%
Hiv Infection: 1 person, 7.14%
Folliculitis (infection of hair root): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Ambisome and have Blind?

- Check whether Blind is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ambisome:

Ambisome (7,934 reports)

Blind treatments and more:

Blind (45,948 reports)

Browse all side effects of Ambisome:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Blind:

Blind (2,281 drugs)

Browse all the conditions that are associated with Blind:

Blind (1,972 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on amphotericin b (the active ingredients of Ambisome) and Ambisome (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.